Immune Checkpoint Inhibitors and Their Role in Enhancing Antitumor Immunity in the Tumor-Draining Lymph Nodes
The immune checkpoint inhibitors market is estimated to be worth $12 billion in 2030 and is expected to grow at CAGR of 15% during the forecast period.
Read More : https://www.rootsanalysis.com/....reports/immune-check
Cancer is known to be one of the leading causes of death worldwide, accounting for 0.6 million deaths in 2019, in the US alone. The World Health Organization has estimated the number of new cancer cases to rise by 70% over the next 20 years, across the globe. Conventional treatment options, such as chemotherapy, surgery and radiation therapy, are still considered as the current standard of care.
Like
Comment
Share
